Table 4.
Vaccinees (n = 99) | Placebos (n = 100) | |||
---|---|---|---|---|
n | % | n | % | |
IgM+ | 1 | 1.0 | 5 | 5.0 |
IgG+ | 9 | 9.1 | 5 | 5.0 |
IgA+ | 0 | 0.0 | 2 | 2.0 |
IgM + IgG+ | 11 | 11.1 | 4 | 4.0 |
IgM + IgA+ | 0 | 0.0 | 0 | 0.0 |
IgG + IgA+ | 7 | 7.1 | 3 | 3.0 |
IgM + IgG + IgA+ | 68 | 68.7 | 1 | 1.0 |
Ab-negative | 3 | 3.0 | 80 | 80.0 |
Percentage of subjects positive for 1, 2 or 3 anti-Tat Ab subclasses at any given time point after the first immunization
n number of subjects